XML 31 R4.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated statements of operations and comprehensive loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Operating expenses:    
Research and development $ 54,168 $ 32,197
General and administrative 31,897 20,847
Total operating expenses 86,065 53,044
Loss from operations (86,065) (53,044)
Other income (expense):    
Interest income (expense), net 120 700
Other income (expense), net 140 101
Total other income (expense) 260 801
Net loss $ (85,805) $ (52,243)
Net loss per share—basic and diluted $ (2.34) $ (1.56)
Weighted average common shares outstanding—basic and diluted 36,739,269 33,488,456
Comprehensive loss:    
Net loss $ (85,805) $ (52,243)
Other comprehensive loss:    
Unrealized loss on marketable securities (168)  
Total other comprehensive loss (168)  
Comprehensive loss $ (85,973) $ (52,243)